TAMPA, Fla.--(BUSINESS WIRE)--Pilgrim Quality Solutions, a leading global provider of enterprise quality management software and services for the Life Sciences, today announced it will be exhibiting at the Drug Information Association (DIA) 29th Annual EuroMeeting, Translational Health Care: From Bench to Bedside and Back, March 29-31, 2017, in Glasgow, Scotland. Pilgrim will showcase its latest product innovations, and help attendees understand how automating their organization’s quality management system (QMS) can improve key operational metrics and reduce their overall cost of quality.
During the conference, Pilgrim representatives will conduct snapshot quality maturity assessments with a quick 5-question form designed to gauge respondents’ current organizational maturity levels. The resulting baseline Cost of Quality estimate will help respondents understand how their company is performing compared to the industry, and quantify the savings and benefits of developing a path to quality leadership within their organization.
“A company’s quality maturity level, risk tolerance, business complexity, and user adoption are key drivers in determining the focus and path that it will take on its quality management journey,” said Pilgrim CEO Rick Lowrey. “Industry research shows that a QMS that aligns with focused strategy and organizational commitment, can significantly reduce overall cost of quality. Taking an assessment at Pilgrim’s EuroMeeting booth, or on our website, will reveal how quality maturity can have significant bottom-line cost savings, which makes quality system improvements a compelling investment for any organization.”
EuroMeeting 2017 will bring together more than 2,000 global health care professionals in the pharmaceutical, biotechnology, and medical device communities to participate in collaborative sessions and debates focused on practical solutions, as well as, longer-term impacts of issues affecting drug development throughout Europe. This year’s theme specifically highlights the critical role patient input plays throughout the lifecycle of drug development.
For more information on Pilgrim Quality Solutions’ full product suite, visit Pilgrim at the 29th Annual EuroMeeting in Booth #B-18, or on the Web at http://www.pilgrimquality.com.
Founded in 1964, DIA (the Drug Information Association) is an international, nonprofit, multidisciplinary association that fosters innovation for improved health and well-being worldwide. DIA provides international professionals a neutral and transparent forum for the exchange of ideas and collaboration to improve health globally through the advancement of lifesaving medicines and technologies. DIA offers knowledge resources and forums on product development, regulatory science, and therapeutic innovation for professionals in the pharmaceutical, biotechnology, and medical device communities. www.DIAglobal.org
About Pilgrim Quality Solutions
Pilgrim Quality Solutions is the leader in quality compliance management software and services for Life Sciences. For more than 20 years, our solutions have automated thousands of processes across global company sites to manage the quality and compliance of life’s most important products. Our cloud-based and on-premise solutions include in-the-box best practice workflows, document and process management, dashboards, electronic signatures, audit trails, and automated validation – helping companies more easily achieve quality system compliance and pass regulatory audits. Pilgrim Quality Solutions is majority owned by Boston-based private equity firm, Riverside Partners LLC. With Pilgrim Quality Solutions as your partner, you are prepared to succeed. For more information, visit www.pilgrimquality.com.